Tata Chemicals Ltd.

As of November 28, 2025, Tata Chemicals exhibits a strong bearish trend, supported by multiple indicators including bearish MACD, Bollinger Bands, and moving averages across weekly and monthly time frames.

As of 18-Nov, Tata Chemicals Ltd. is facing a decline in stock price, currently at 825.30, reflecting a bearish trend with significant underperformance compared to the Sensex. The company's profits have decreased by 41.2%, raising concerns about its long-term growth prospects despite trading at a discount to peers.

As of November 6, 2025, Tata Chemicals is considered overvalued due to its high PE ratio of 60.22 and poor stock performance, significantly underperforming the Sensex with a return of -24.10%.

As of November 3, 2025, Tata Chemicals is fairly valued with a PE ratio of 60.36 and has underperformed the market with a year-to-date return of -16.60%, indicating challenges in delivering strong returns compared to peers.

As of 03-Nov, Tata Chemicals Ltd. is facing a decline in its stock price, currently at 875.25, down 1.74%. The stock has underperformed significantly over the past year and is trading below all major moving averages, indicating a bearish trend and lack of investor confidence.

As of October 31, 2025, Tata Chemicals is considered very attractive with a PE ratio of 51.11 and a PEG ratio of 0.00, indicating it is undervalued compared to peers like Adani Enterprises and SRF, despite a recent stock decline of 22.46% over the past year.

Tata Chemicals' latest Q2 FY26 results are concerning, showing a significant decline in net profit to ₹77 crores and a contraction in operating margins, indicating operational challenges and reliance on non-operating income amidst rising costs and competitive pressures.

As of October 31, 2025, Tata Chemicals is considered a very attractive investment due to its undervalued metrics, including a PE ratio of 51.11 and a PEG ratio of 0.00, despite a year-to-date stock performance lagging behind the Sensex.

Tata Chemicals has shown a declining trend in net sales and profitability, with net sales dropping from 16,789 Cr in Mar'23 to 14,887 Cr in Mar'25, and profit after tax decreasing from 381 Cr to 200 Cr in the same period. The company's operating profit margin also fell significantly, indicating reduced operational efficiency.

As of October 31, 2025, Tata Chemicals is considered very attractive and undervalued with a PE Ratio of 51.11 and an EV to EBITDA of 13.98, making it a compelling investment opportunity compared to its more expensive peers like Adani Enterprises and SRF.

As of October 28, 2025, Tata Chemicals is considered overvalued due to its high PE ratio of 51.84 and low ROE of 1.54%, despite a strong historical return, indicating a shift in market perception from very attractive to attractive.

Tata Chemicals has experienced a decline in net sales and profits from Mar'23 to Mar'25, with net sales dropping from 16,789 Cr to 14,887 Cr and profit after tax falling from 2,454 Cr to 200 Cr, despite an increase in total assets and liabilities. The company's profitability challenges are further reflected in decreased operating profit and cash flow from operating activities.

As of October 27, 2025, Tata Chemicals is considered undervalued with a PE ratio of 51.28 and an attractive valuation grade, despite underperforming the Sensex with a year-to-date return of -14.84%, which may present a buying opportunity compared to its higher-priced peers like Adani Enterprises and SRF.